Product image of Metoclopramide Genethics Europe (Metoclopramide Hydrochloride) supplied by GNH India

Metoclopramide Genethics Europe

Active Ingredient:
Metoclopramide Hydrochloride
Origin:
EU

Metoclopramide Genethics Europe (Metoclopramide Hydrochloride)

Metoclopramide Hydrochloride, the active ingredient in Metoclopramide Genethics Europe, is a dopamine D2 receptor antagonist presented as an oral formulation for systemic use. It treats nausea, vomiting and related gastrointestinal motility disorders in adults, including gastroparesis and gastroesophageal reflux disease.

GNH India supplies Metoclopramide Genethics Europe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Genethics Europe Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Metoclopramide is used to manage disorders of nausea, vomiting and gastrointestinal motility.
  • Nausea and vomiting: Reduces frequency and severity of symptoms by blocking dopamine receptors in the chemoreceptor trigger zone.
  • Gastroparesis: Improves gastric emptying and alleviates related discomfort.
  • Gastroesophageal reflux disease: Enhances lower esophageal sphincter tone and promotes gastric clearance.

How It Works

  • Metoclopramide Hydrochloride antagonizes dopamine D2 receptors in the chemoreceptor trigger zone, reducing nausea signals, while simultaneously stimulating gastrointestinal motility by enhancing acetylcholine release. It also blocks 5‑HT3 receptors and agonises 5‑HT4 receptors, further promoting gastric emptying and improving lower esophageal sphincter tone.

Side Effects

Metoclopramide may cause a range of adverse reactions.

Common Side Effects

  • Drowsiness: feeling of sleepiness or reduced alertness.
  • Fatigue: general lack of energy.
  • Restlessness: inner sense of unease or agitation.
  • Diarrhea: loose, frequent stools.

Serious or Rare Side Effects

  • Tardive dyskinesia: involuntary, repetitive movements that may be irreversible.
  • Neuroleptic malignant syndrome: high fever, muscle rigidity, and autonomic instability.
  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Cardiac arrhythmia: irregular heart rhythm requiring medical attention.

Precautions & Warnings

When prescribing Metoclopramide, several safety considerations apply.

  • Pregnancy: Use only if potential benefit justifies risk; safety not established.
  • Breastfeeding: Caution advised; drug may be excreted in milk.
  • Elderly patients: Start with lower dose and monitor for extrapyramidal symptoms.
  • Renal impairment: Adjust dose as needed and monitor renal function.
  • CNS disorders: Use cautiously in patients with Parkinson's disease or seizure disorders.
  • Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Avoid Interactions

Metoclopramide can interact with several medicines.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
  • Anticholinergic agents: may increase anticholinergic side effects.
  • CNS depressants (e.g., opioids, benzodiazepines): enhanced sedation and respiratory depression.
  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increased metoclopramide plasma levels.

Moderate Interactions (Monitor Closely)

  • Antipsychotics (e.g., haloperidol): additive extrapyramidal effects.
  • Digoxin: possible increase in digoxin levels.
  • Alcohol: may potentiate central nervous system effects.
  • Proton pump inhibitors: may affect absorption.

Frequently Asked Questions

Metoclopramide Genethics Europe is a prescription medication indicated for the treatment of nausea and vomiting, for managing gastroparesis by enhancing gastric emptying, and for supporting patients with gastroesophageal reflux disease through its pro‑kinetic effects.

The drug blocks dopamine D2 receptors in the chemoreceptor trigger zone, which reduces nausea signals, and it stimulates gastrointestinal motility by antagonising 5‑HT3 and agonising 5‑HT4 receptors, thereby promoting gastric emptying and improving lower esophageal sphincter tone.

The appropriate dose of Metoclopramide is determined by the prescribing healthcare professional based on the patient’s specific condition, age, renal function and overall clinical assessment. No fixed regimen is provided here.

Safety data for Metoclopramide in pregnancy are limited, so it should only be used when the potential benefit outweighs any risk. During breastfeeding, caution is advised because the drug can be excreted in milk; a clinician should evaluate the risk‑benefit ratio.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoclopramide differs from many antiemetics by combining dopamine antagonism with pro‑kinetic activity, which can improve gastric motility. Other agents, such as ondansetron, act primarily on serotonin receptors without affecting motility, making Metoclopramide useful when delayed gastric emptying contributes to symptoms.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Metoclopramide Genethics Europe is supplied as an oral formulation and is taken by mouth with or without food, as directed by the prescribing clinician. The exact administration schedule should follow the healthcare professional’s instructions.

Serious adverse effects include tardive dyskinesia, a potentially irreversible movement disorder, neuroleptic malignant syndrome characterized by high fever and muscle rigidity, severe allergic reactions, and cardiac arrhythmias. Patients should be monitored closely for any of these events.

Metoclopramide is contraindicated in individuals with known hypersensitivity to the drug, in patients with pheochromocytoma, and in those with a history of seizure disorders or severe depression where the medication could exacerbate symptoms. It should also be avoided in patients taking MAO inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metoclopramide Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT